Literature DB >> 28706039

When an emerging disease becomes endemic.

Graham F Medley1, Anna Vassall2.   

Abstract

Epidemics, such as HIV in the early 1980s and Ebola in 2014, inspire decisive government investment and action, and individual and societal concern, sometimes bordering on panic. By contrast, endemic diseases, such as HIV in 2017 and tuberculosis, struggle to maintain the same attention. For many, the paradox is that endemic disease, in its totality, continues to impose a far higher public health burden than epidemic disease. Overall, the swift political response to epidemics has resulted in success. It has proven possible to eradicate epidemic diseases, often without the availability of vaccines and other biomedical technologies. In recent times, only HIV has made the transition from epidemic to endemic, but diseases that have existed for centuries continue to cause most of the infectious disease burden.
Copyright © 2017, American Association for the Advancement of Science.

Entities:  

Mesh:

Year:  2017        PMID: 28706039     DOI: 10.1126/science.aam8333

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  11 in total

Review 1.  Emerging reverse transcriptase inhibitors for HIV-1 infection.

Authors:  Mohammad A Rai; Sam Pannek; Carl J Fichtenbaum
Journal:  Expert Opin Emerg Drugs       Date:  2018-05-10       Impact factor: 4.191

2.  Count the cost of disability caused by COVID-19.

Authors:  Andrew Briggs; Anna Vassall
Journal:  Nature       Date:  2021-05       Impact factor: 49.962

3.  Mass Gatherings and Diarrheal Disease Transmission Among Rural Communities in Coastal Ecuador.

Authors:  Philip A Collender; Christa Morris; Rose Glenn-Finer; Andrés Acevedo; Howard H Chang; James A Trostle; Joseph N S Eisenberg; Justin V Remais
Journal:  Am J Epidemiol       Date:  2019-08-01       Impact factor: 4.897

4.  Diagnostic tools for soil-transmitted helminths control and elimination programs: A pathway for diagnostic product development.

Authors:  Mark D Lim; Simon J Brooker; Vicente Y Belizario; Françoise Gay-Andrieu; John Gilleard; Bruno Levecke; Lisette van Lieshout; Graham F Medley; Zeleke Mekonnen; Greg Mirams; Sammy M Njenga; Maurice R Odiere; James W Rudge; Lieven Stuyver; Jozef Vercruysse; Johnny Vlaminck; Judd L Walson
Journal:  PLoS Negl Trop Dis       Date:  2018-03-01

5.  The Evolution of Pediatric Disease-A Moving Target in Public Health.

Authors:  Mark A Brown
Journal:  Diseases       Date:  2017-08-31

Review 6.  Barrier Precautions in the Era of Multidrug Pathogens.

Authors:  Rachel Pryor; Carli Viola-Luqa; Olivia Hess; Gonzalo Bearman
Journal:  Curr Treat Options Infect Dis       Date:  2020-06-29

7.  Travel, Migration and Emerging Infectious Diseases.

Authors:  Nicolas Vignier; Olivier Bouchaud
Journal:  EJIFCC       Date:  2018-11-07

8.  System dynamics modeling of public health services provided by China CDC to control infectious and endemic diseases in China.

Authors:  Meina Li; Wenya Yu; Wei Tian; Yang Ge; Yuan Liu; Tao Ding; Lulu Zhang
Journal:  Infect Drug Resist       Date:  2019-03-13       Impact factor: 4.003

9.  COVID-19: Taiwan's epidemiological characteristics and public and hospital responses.

Authors:  Chih-Ming Chang; Ting-Wan Tan; Tai-Cheng Ho; Chung-Chu Chen; Tsung-Hsien Su; Chien-Yu Lin
Journal:  PeerJ       Date:  2020-06-09       Impact factor: 2.984

10.  Prevalence and risk factors of worry among teachers during the COVID-19 epidemic in Henan, China: a cross-sectional survey.

Authors:  Yanqing Wang; Quanman Li; Clifford Silver Tarimo; Cuiping Wu; Yudong Miao; Jian Wu
Journal:  BMJ Open       Date:  2021-07-07       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.